The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...
Colossal Biosciences announced a new partnership with the University of Tasmania to combat devil facial tumour disease, a contagious cancer that has devastated the Tasmanian devil since it was first ...
The Trump administration has proposed what experts are calling “an unprecedented shift” in the way the federal government determines how to distribute grant funding.The most significant change ...
New research could help make future mRNA vaccines easier to store and distribute. The study, involving RMIT University, the ...
A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
I see it often. Hardworking professionals in cafés, airports, or parks hunched over a laptop while carefully dragging their fingers over their PC’s trackpad to navigate some email, project, or alert ...
For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must ...
Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...
Interferon receptor knockout chickens uncover how type I and III interferons differentially shape avian antiviral immunity and influenza disease outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results